Stay updated on Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.

Latest updates to the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check10 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check53 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial for gastric cancer and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference9%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check67 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab Plus Nivolumab in Gastric Cancer Clinical Trial page.